Javid Baksh, DO
Pain Medicine · Asheville, NCNPI 1447413190
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 92.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $31,223 and has fallen 92.7% since, to $2,270 in 2025. Among pain medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,666 payments — averaging $43.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$107K
- Medtronic$3K
- Vertos Medical, Inc.$2K
- Si-bone, Inc.$1K
- Spinal Simplicity, LLC$678
- Nalu Medical, Inc.$343
- plus $1K from 21 others
Across 62 payments — averaging $1387.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$85K
- Painteq LLC$775
What the payments were for
- Consulting fees$41,52736%
- Speaking & faculty fees$12,21911%
- Travel & lodging$3060%
- Food & beverage$61,79753%
- Education$410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2,415 | $107,116 |
| Medtronic | 122 | $3,456 |
| Vertos Medical, Inc. | 48 | $1,873 |
| Si-bone, Inc. | 14 | $1,008 |
| Spinal Simplicity, LLC | 9 | $678 |
| Nalu Medical, Inc. | 8 | $343 |
| Relievant Medsystems, Inc. | 9 | $258 |
| Boston Scientific | 5 | $196 |
| Foundation Fusion Solutions, LLC | 1 | $140 |
| Painteq LLC | 1 | $128 |
| Flowonix Medical Incorporated | 1 | $108 |
| Tersera Therapeutics LLC | 4 | $101 |
| Fidia Pharma USA Inc. | 4 | $67 |
| Vertiflex, Inc. | 3 | $65 |
| MDD US Operations, LLC | 4 | $52 |
| AbbVie(2 entities) | 3 | $52 |
| Stimwave Technologies Incorporated | 3 | $46 |
| Pacira Therapeutics, Inc. | 1 | $33 |
| Forte Bio-pharma LLC | 1 | $32 |
| Sentynl Therapeutics, Inc. | 2 | $27 |
| Bioventus LLC | 2 | $24 |
| Stryker | 1 | $20 |
| Piramal Critical Care | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$20,494
- Proclaim Family of SCS IPGs$18,546
- Neuromodulation Dspsbls and Accs$14,536
- Proclaim IPG$10,917
- INCEPTIV$1,004
- mild Device Kit$941
- OCTRODE$415
- HA MINUTEMAN G3-R$336
- Octrode SCS Leads$309
- Nalu Neurostimulation System$254
- iFuse Implant$252
- CardioMEMS HF System$207
- INTELLIS ADAPTIVESTIM$168
- Penta SCS Leads$145
- PAINTEQ$128
- Minuteman$123
- Axium INS DRG IPG$112
- Prometra II$108
- VANTA ADAPTIVESTIM$108
- Prodigy Family of SCS IPGs$100
How this compares
$115,890 in reported general payments places this provider in the 95th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 238 | $112,234 |
| BelbucaBuprenorphine Hcl | 135 | $92,831 |
| Buprenorphine | 372 | $76,281 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,215 | $61,366 |
| OxycontinOxycodone Hcl | 112 | $48,835 |
| MovantikNaloxegol Oxalate | 102 | $45,452 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,012 | $44,716 |
| RelistorMethylnaltrexone Bromide | 13 | $31,090 |
| Oxycodone Hcl | 1,776 | $26,883 |
| NucyntaTapentadol Hcl | 23 | $21,488 |
| Nucynta ErTapentadol Hcl | 20 | $20,615 |
| LinzessLinaclotide | 25 | $14,699 |
| Fentanyl | 169 | $13,285 |
| SymproicNaldemedine Tosylate | 24 | $12,651 |
| Naloxone Hcl | 147 | $9,927 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $52 | $14,69925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 182 pain medicine providers in North Carolina.
Other pain medicine in Asheville
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- David ZubLeland$97K
- James DeeringCharlotte$93K
- David CiochettyChapel Hill$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.